JCE offers a large-cap equity portfolio with a call-overlay strategy, suitable for income-focused investors. Read the full ...

Whenever tensions rise between the US and Iran, the “perpetual purveyors of doom” quickly start posting clips stating that ...

Kraken Robotics (KRKNF) shifts to commercialization in defense UUV/AUVs; Q3 growth driven by acquisitions, 2025 guide ...

Discover the $1T software stock wipeout and an overlooked 11%+ yielding opportunity to profit from SaaS carnage. Read more macro analysis here.

Organon reported a disappointing Q4, with revenue down 5% YoY and significant weakness in Women's Health. Find out why OGN ...

Supreme Court tariffs ruled invalid, but Trump’s 15% tariff adds uncertainty. Read more on what investors should know about ...

Hedge funds were split on Amazon (AMZN) in Q4 2025 as Berkshire cut big while Pershing, Point72 and Baupost added.

OMAH's equity portfolio mirrors Berkshire Hathaway’s top holdings, plus direct BRK exposure. Click here to read why OMAH ...

Merck started 2026 on a high note. Read why MRK stock is still one of the best choices among Big Pharma players for long-term-oriented investors.

Transitioning to long-term agreements could reduce cyclicality for Sandisk but introduces risks if not carefully negotiated.

Morgan Stanley management now also appears to be quite confident it can sustain a 20% return on tangible common equity ...

MSTY is a fund that allows investors to gain income on a very volatile asset, which is further amplified by the swings of BTC. Learn why the MSTY ETF is a buy.